Literature DB >> 31253538

Agreement between skeletal muscle mass measurements using computed tomography imaging and magnetic resonance imaging in head and neck cancer patients.

N Chargi1, E Ansari1, L F J Huiskamp1, G Bol2, R de Bree3.   

Abstract

Entities:  

Year:  2019        PMID： 31253538     DOI： 10.1016/j.oraloncology.2019.06.022

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  8 in total

1.  Reply to comment on "Sarcopenia is a prognostic factor for overall survival in elderly patients with head and neck cancer".

Authors:  N Chargi; S I Bril; P A de Jong; M H Emmelot-Vonk; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-08       Impact factor: 2.503

2.  Image-based analysis of skeletal muscle mass predicts cisplatin dose-limiting toxicity in patients with locally advanced head and neck cancer.

Authors:  Najiba Chargi; Fereshta Bashiri; Anne W Wendrich; Ernst J Smid; Pim A de Jong; Alwin D R Huitema; Lot A Devriese; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-17       Impact factor: 2.503

3.  Cut-off values for low skeletal muscle mass at the level of the third cervical vertebra (C3) in patients with head and neck cancer.

Authors:  Najiba Chargi; Sandra I Bril; Ernst J Smid; Pim A de Jong; Remco de Bree
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 4.  Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty.

Authors:  Remco de Bree; Christiaan D A Meerkerk; Gyorgy B Halmos; Antti A Mäkitie; Akihiro Homma; Juan P Rodrigo; Fernando López; Robert P Takes; Jan B Vermorken; Alfio Ferlito
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

5.  The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis.

Authors:  Laura F J Huiskamp; Najiba Chargi; Lot A Devriese; Anne M May; Alwin D R Huitema; Remco de Bree
Journal:  J Clin Med       Date:  2020-11-23       Impact factor: 4.241

6.  Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.

Authors:  Najiba Chargi; Omar Breik; Tymour Forouzanfar; Timothy Martin; Prav Praveen; Matthew Idle; Satyesh Parmar; Remco de Bree
Journal:  Head Neck       Date:  2022-06-02       Impact factor: 3.821

7.  Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.

Authors:  Aniek T Zwart; Jan-Niklas Becker; Maria J Lamers; Rudi A J O Dierckx; Geertruida H de Bock; Gyorgy B Halmos; Anouk van der Hoorn
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

8.  The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy.

Authors:  L F J Huiskamp; N Chargi; L A Devriese; P A de Jong; R de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-25       Impact factor: 2.503
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.